Stable analogs of peptide and polypeptide therapeutics

Details Stable analogs of peptide and polypeptide therapeutics Stable analogs of peptide and polypeptide therapeutics

2011-08-09

2011-08-09

Gupta, Anish (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021300, C514S021400, C530S308000, C530S324000, C530S325000, C530S326000

Reexamination Certificate

active

07994121

ABSTRACT:
The present invention relates to compositions of peptide and polypeptide analogs that are resistant to proteolysis, pharmaceutical uses thereof, and methods of preparation thereof.

REFERENCES:
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
patent: 5276137 (1994-01-01), Ojima et al.
patent: 5545618 (1996-08-01), Buckley et al.
patent: 5614492 (1997-03-01), Habener
patent: 5766620 (1998-06-01), Heiber et al.
patent: 5958909 (1999-09-01), Habener
patent: 5994500 (1999-11-01), Drucker et al.
patent: 6184201 (2001-02-01), Drucker et al.
patent: 6268343 (2001-07-01), Knudsen et al.
patent: 6277819 (2001-08-01), Efendic et al.
patent: 6358924 (2002-03-01), Hoffmann
patent: 6489295 (2002-12-01), Drucker et al.
patent: 7259234 (2007-08-01), Bachovchin et al.
patent: 2001/0011071 (2001-08-01), Knudsen et al.
patent: 2004/0242853 (2004-12-01), Greig et al.
patent: WO-99/40788 (1999-08-01), None
patent: WO-99/43705 (1999-09-01), None
patent: WO-99/43706 (1999-09-01), None
patent: WO-99/43707 (1999-09-01), None
patent: WO-00/07617 (2000-02-01), None
patent: WO-01/98331 (2001-12-01), None
patent: WO-02/22151 (2002-03-01), None
patent: WO-02/46227 (2002-06-01), None
patent: WO-/02 47716 (2002-06-01), None
patent: WO-02/069994 (2002-09-01), None
patent: WO-03/002136 (2003-01-01), None
patent: WO-03/018516 (2003-03-01), None
Define Polypeptide at Dictionary.com [retrieved on May 4, 2010]. Retrieved from the Internet <URL: http://dictionary.reference.com/browse/polypeptide>.
Deacon et al., “Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity”,Diabetologia, 41(3):271-278 (1998).
Guarita, et al., “PYY Regulates Pacreatic Exocrine Secretion Through Multiple Receptors in the Awake Rat”,Digestive Diseases and Sciences, 45(9):1696-1702 (2000).
Keire, et al., “Structure and receptor binding of PYY analogs”,Peptides, 23:305-321 (2002).
Mentlein, R., “Dipeptidyl-peptidase IV (?CD26)-role in the inactivation of regulatory peptides”,Regulatory Peptides, 85:9-24 (1999).
Mentlein et al., “Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36) amide, peptide histidine methionine and is responsible for their degradation in human serum”,European Journal of Biochemistry, 214(3):829-835 (1993).
Naslund, et al., “Glucagon-like peptide-1 analogue LY315902: Effect on intestinal motility and release of insulin and somatostatin”,Regulatory Peptides, 106:89-95 (2002).

Affiliated with

Also associated with

Rating

Stable analogs of peptide and polypeptide therapeutics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable analogs of peptide and polypeptide therapeutics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable analogs of peptide and polypeptide therapeutics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2695264